Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
B-cell lymphoma
Research
Innate antibody pits NK cells against lymphoma in animal models
The antibody, called IPH6501, is now being evaluated in a phase 1/2 trial in patients with relapsed or unresponsive B cell non-Hodgkin lymphoma.
Darren Incorvaia
Nov 15, 2024 2:00pm
Cullinan rebrands, halts lymphoma trial in autoimmune refocus
Apr 16, 2024 10:05am
Oncternal reports patient death in CAR-T dose-escalation study
Dec 28, 2023 10:52am
Cargo, undeterred by market challenges, seeks $281M IPO
Nov 10, 2023 10:00am
Caribou heads 'where the puck is going' with cell therapy plan
Jun 6, 2023 2:25pm
ASH: Should existing BTKs worry about Lilly's newcomer?
Dec 12, 2022 5:30pm
